Silvia Tortorella

Dr. Silvia Tortorella

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
STSilvia Tortorella
Silvia Tortorella
VBVeronica Vetri Buratti
Veronica Vetri Buratti
Mirko MaturiMirko Maturi
Mirko Maturi
Letizia SambriLetizia Sambri
Letizia Sambri
Mauro Comes-FranchiniMauro Comes-Franchini
Mauro Comes-Franchini
Erica LocatelliErica Locatelli
Erica Locatelli
Presently, a plenty of concerns related to the environment are due to the overuse of petroleum-based chemicals and products; the synthesis of functional materials, starting from the natural sources, is the current trend in research. The interest for nanocellulose has recently increased in a huge range of fields, from the material science to the biomedical engineering. Nanocellulose gained this leading role because of several reasons: its natural abundance on this planet, the excellent mechanical and optical features, the good biocompatibility and the attractive capability of undergoing surface chemical modifications. Nanocellulose surface tuning techniques are adopted by the high reactivity of the hydroxyl groups available; the chemical modifications are mainly performed to introduce either charged or hydrophobic moieties that include amination, esterification, oxidation, silylation, carboxymethylation, epoxidation, sulfonation, thiol- and azido-functional capability. Despite the several already published papers regarding nanocellulose, the aim of this review involves discussing the surface chemical functional capability of nanocellulose and the subsequent applications in the main areas of nanocellulose research, such as drug delivery, biosensing/bioimaging, tissue regeneration and bioprinting, according to these modifications. The final goal of this review is to provide a novel and unusual overview on this topic that is continuously under expansion for its intrinsic sophisticated properties.

6 December 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
STSilvia Tortorella
Silvia Tortorella
Mirko MaturiMirko Maturi
Mirko Maturi
VBVeronica Vetri Buratti
Veronica Vetri Buratti
GVGiulia Vozzolo
Giulia Vozzolo
Erica LocatelliErica Locatelli
Erica Locatelli
Mauro Comes-FranchiniMauro Comes-Franchini
Mauro Comes-Franchini
Zein a versatile biomaterial in the biomedical field. Easy to chemically functionalize with good emulsification properties, can be employed in drug delivery, fabrication of bioactive membranes and 3D scaffolds for tissue regeneration.

22 December 2016 in Diagnostics
Verified
Journal Article
Open access
PDF file
Carla FerreriCarla Ferreri
Carla Ferreri
Annalisa MasiAnnalisa Masi
Annalisa Masi
ASAnna Sansone
Anna Sansone
GGGiorgia Giacometti
Giorgia Giacometti
ALAnna Vita Larocca
Anna Vita Larocca
Chryssostomos ChatgilialogluChryssostomos Chatgilialoglu
Chryssostomos Chatgilialoglu
Fatty acids, as structural components of membranes and inflammation/anti-inflammatory mediators, have well-known protective and regulatory effects. They are studied as biomarkers of pathological conditions, as well as saturated and unsaturated hydrophobic moieties in membrane phospholipids that contribute to homeostasis and physiological functions. Lifestyle, nutrition, metabolism and stress—with an excess of radical and oxidative processes—cause fatty acid changes that are examined in the human body using blood lipids. Fatty acid-based membrane lipidomics represents a powerful diagnostic tool for assessing the quantity and quality of fatty acid constituents and also for the follow-up of the membrane fatty acid remodeling that is associated with different physiological and pathological conditions. This review focuses on fatty acid biomarkers with two examples of recent lipidomic research and health applications: (i) monounsaturated fatty acids and the analytical challenge offered by hexadecenoic fatty acids (C16:1); and (ii) the cohort of 10 fatty acids in phospholipids of red blood cell membranes and its connections to metabolic and nutritional status in healthy and diseased subjects.

1 November 2016 in Organic Electronics
Verified
Journal Article
Open access
SDSimon Desbief
Simon Desbief
MLMichele di Lauro
Michele di Lauro
Stefano CasaliniStefano Casalini
Stefano Casalini
DGDavid Guerin
David Guerin
STSilvia Tortorella
Silvia Tortorella
DVDominique Vuillaume
Dominique Vuillaume
We demonstrate an electrolyte-gated hybrid nanoparticle/organic synapstor (synapse-transistor, termed EGOS) that exhibits short-term plasticity as biological synapses. The response of EGOS makes it suitable to be interfaced with neurons: short-term plasticity is observed at spike voltage as low as 50 mV (in a par with the amplitude of action potential in neurons) and with a typical response time in the range of tens milliseconds. Human neuroblastoma stem cells are adhered and differentiated into neurons on top of EGOS. We observe that the presence of the cells does not alter short-term plasticity of the device.Comment: Full paper, figures and supporting informatio

9 September 2020 in Green Chemistry
Verified
Journal Article
Open access
PDF file
Mirko MaturiMirko Maturi
Mirko Maturi
CPCarolina Pulignani
Carolina Pulignani
Erica LocatelliErica Locatelli
Erica Locatelli
VBVeronica Vetri Buratti
Veronica Vetri Buratti
STSilvia Tortorella
Silvia Tortorella
Mauro Comes-FranchiniMauro Comes-Franchini
Mauro Comes-Franchini
Since the advent of polymer-based 3D printing technology, the scientific community has directed great effort towards the development of new polymeric formulations that would allow applying this technique to various fields of application, ranging from materials science to tissue engineering. However, most of the available materials are nevertheless oil-based and cost-ineffective. This work presents a novel bio-based resin for stereolithographic DLP 3D printing formulated by mixing a photocurable polyester obtained from renewable resources (poly(1,3-propanediyl-co-glyceryl) itaconate-co-vanillate, PPGIV) with methacrylated citrate and itaconate crosslinkers (bis(HEMA) itaconate, BHI, and tris(HEMA) citrate, THC) and appropriate photopolymerization initiators, terminators and dyes. As a proof-of-concept, a photocurable ink is formulated with phosphorescent Ir(III) cyclometalated complexes and its potential applications have been demonstrated for both rigid and flexible structures.

18 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Simona CamoraniSimona Camorani
Simona Camorani
STSilvia Tortorella
Silvia Tortorella
LALisa Agnello
Lisa Agnello
CSChiara Spanu
Chiara Spanu
ADAnnachiara D’argenio
Annachiara D’argenio
Laura CerchiaLaura Cerchia
Laura Cerchia
Small interfering RNA (siRNA) therapies require effective delivery vehicles capable of carrying the siRNA cargo into target cells. To achieve tumor-targeting, a drug delivery system would have to incorporate ligands that specifically bind to receptors expressed on cancer cells to function as portals via receptor-mediated endocytosis. Cell-targeting and internalizing aptamers are the most suitable ligands for functionalization of drug-loaded nanocarriers. Here, we designed a novel aptamer-based platform for the active delivery of siRNA targeting programmed cell death-ligand 1 (PD-L1) to triple-negative breast cancer (TNBC) cells. The generated nanovectors consist of PLGA-based polymeric nanoparticles, which were loaded with PD-L1 siRNA and conjugated on their surface with a new RNA aptamer, specific for TNBC and resistant to nucleases. In vitro results demonstrated that these aptamer-conjugated nanoparticles promote siRNA uptake specifically into TNBC MDA-MB-231 and BT-549 target cells, along with its endosomal release, without recognizing non-TNBC BT-474 breast cancer cells. Their efficiency resulted in an almost complete suppression of PD-L1 expression as early as 90 min of cell treatment. This research provides a rational strategy for optimizing siRNA delivery systems for TNBC treatments.